Tag: CanniMed

Aurora Continues to Question CanniMed Deal to Acquire Newstrike

Aurora Cannabis to File Dissident Circular Against Proposed CanniMed-Newstrike Combination Proposed Transaction Highly Dilutive and Wholly Inadequate for CanniMed Shareholders Aurora Appoints PI Financial as Advisor in Relation to...
- December 18th, 2017 at 7:33 am

Aurora Cannabis Remains Committed to CanniMed Takeover

Aurora Cannabis Responds to CanniMed’s Adoption of Poison Pill Tactic Reaffirms Commitment to Offer and Invitation to Tender Poison Pill Strips CanniMed Shareholders of Rights and Restricts Choices Not...
- November 30th, 2017 at 8:45 pm

Aurora Cannabis Launches CanniMed Hostile Takeover Bid

Aurora Cannabis Launches Takeover Bid for CanniMed, Invites CanniMed Shareholders to Tender to the Bid Offer currently valued at $24.00 per CanniMed share 56.9% premium to CanniMed closing price...
- November 24th, 2017 at 8:28 am

Aurora Cannabis to Launch CanniMed Hostile Takeover Bid

Aurora Cannabis Announces Intention to Launch Takeover Bid for CanniMed Therapeutics Inc. Provides Comments on CanniMed’s Poison Pill Tactic Aurora’s proposed offer currently valued at $24.00 per CanniMed share...
- November 20th, 2017 at 7:50 am

How Cannabis Oils Are Driving Canadian LP Sales

In September, Health Canada updated market information that showed how oils are growing rapidly. During the quarter ending 6/30, licensed producers (LPs) shipped 5.896mm grams of dried flower, representing...
- October 12th, 2017 at 12:12 pm

Mackie Research Initiates Coverage on Four Canadian LPs

Investment Bank Mackie Research has published an extensive industry report, initiating coverage on four Canadian LPs. The 74-page report, “The End of Prohibition – Investing in Canada’s Growing Cannabis...
- September 20th, 2017 at 4:39 pm

Cannabis ETF Makes Changes After Index Rebalancing

Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), the world’s first and still only cannabis ETF, has adjusted its portfolio this month as its benchmark, the North...
- September 20th, 2017 at 9:30 am

CanniMed Sales Jump 80%

CanniMed Therapeutics Inc. Reports Financial Results for Q3 2017 SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its financial results for the three and nine...
- September 11th, 2017 at 7:40 am

Overexposed Cannabis ETF Hit Hard by Biotech Losses

Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (OTC: HMLSF) has been hit hard over the past two weeks, declining 8.4% since July 26th despite what has been a stable market...
- August 9th, 2017 at 12:46 pm

Canadian Cannabis Stocks Bounce Back

After a big 2nd half of 2016 and some strength in early 2017, Canadian LPs were under heavy pressure from April through June following a glut of supply (new...
- July 28th, 2017 at 3:32 pm

Cannabis Extracts: The Next Canadian Oil Boom

Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015. While these products...
- July 2nd, 2017 at 4:37 pm

Marketing Medical Cannabis Like Branded Generics

Earlier this month, Tilray made a big change in how it will be marketing its medical cannabis products. Historically, it was selling its dried cannabis products under common strain names,...
- June 25th, 2017 at 5:30 pm

Cannabis Now a Global Investment Opportunity

Readers of New Cannabis Ventures likely recall how we alerted to the huge opportunities in Canada last June, and the Canadian market continues to evolve as a leader in the...
- May 11th, 2017 at 10:20 am

How to Invest in Canadian Cannabis Stocks

With Canada set to make history this week by tabling legislation to make the nation the first G-7 country to legalize cannabis for adult use, many investors are focusing...
- April 9th, 2017 at 10:04 am